You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
億帆醫藥(002019.SZ):上半年淨利潤2.53億元,同比增長133.04% 擬10派1元
格隆匯 08-14 20:38

格隆匯8月14日丨億帆醫藥(002019.SZ)發佈2024年半年度報吿,報吿期內公司實現營業收入26.32億元,同比增長35.39%;歸屬於上市公司股東的淨利潤2.53億元,同比增長133.04%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.79億元,同比增長90.48%;基本每股收益0.21元/股。擬向全體股東每10股派發現金紅利1元(含税)。

報吿期內,公司境內藥品製劑業務以突出自有產品為主,同時集中醫學推廣和渠道等優勢資源,實現了國內醫藥自有(含進口)產品營業收入同比增長88.29%,為公司營收結構持續優化和利潤率提高奠定了基礎;同時,若剔除計提的信用減值和資產減值等因素影響後,公司境內藥品製劑業務實現更高增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account